Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Market Closed 09-04 16:00:00 EDT

0.8324

-0.0165

-1.94%

盘后0.8299

-0.0025-0.30%

19:30 EDT

High0.8496	Low0.8211	Vol92.00K
Open0.8403	D1 Closing0.8489	Amplitude3.36%
Mkt Cap3.72M	Tradable Cap3.64M	Total Shares4.47M
T/O76.56K	T/O Rate2.10%	Tradable Shares4.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":0.8324,"timestamp":1788552000000,"preClose":0.8489,"halted":0,"volume":92004,"hourTrading":{"tag":"盘后","latestPrice":0.8299,"preClose":0.8324,"latestTime":"19:30 EDT","volume":4050,"amount":3354.0366,"timestamp":1788564603437,"change":-0.0025,"changeRate":-0.003003,"amplitude":0.013695},"delay":0,"changeRate":-0.01943691836494282,"floatShares":4377183,"shares":4468100,"eps":-6.647665,"marketStatus":"Market Closed","change":-0.0165,"latestTime":"09-04 16:00:00 EDT","open":0.8403,"high":0.8496,"low":0.8211,"amount":76559.4081252,"amplitude":0.033573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.647665,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":0.8489,"preHourTrading":{"tag":"盘前","latestPrice":0.8499,"preClose":0.8489,"latestTime":"09:12 EDT","volume":7576,"amount":6312.7940484,"timestamp":1788527520425,"change":0.001,"changeRate":0.001178,"amplitude":0.040287},"postHourTrading":{"tag":"盘后","latestPrice":0.8299,"preClose":0.8324,"latestTime":"19:30 EDT","volume":4050,"amount":3354.0366,"timestamp":1788564603437,"change":-0.0025,"changeRate":-0.003003,"amplitude":0.013695},"volumeRatio":0.036774863203897536},"requestUrl":"/m/hq/s/BJDX/tweets","defaultTab":"tweets","newsList":[{"id":"2659544111","title":"Bluejay Advances Symphony Platform, Strengthens Cash Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2659544111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659544111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:17","pubTimestamp":1786623474,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has provided an announcement. On August 13, 2026, Bluejay Diagnostics reported second-quarter 2026 results, highlig...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659685153","title":"Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659685153","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659685153?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:17","pubTimestamp":1786616272,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61167382/bluejay-diagnostics-q2-eps-1-12-5-64-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158032","title":"Bluejay Diagnostics Says SYMON-II Pivotal Study Completes Enrollment of 750 Patients for Symphony IL-6 Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:04","pubTimestamp":1786615496,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 testBluejay Diagnostics reported Q2 2026 progress on its SYMON-II pivotal study for the investiga","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLhvCLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117158","title":"Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ Il-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117158?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUAB7ZFPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158166","title":"Press Release: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony(TM) IL-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158166","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158166?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"-- SYMON-II pivotal clinical study completes targeted enrollment of 750. -- Company advances toward planned 510 submission and commercialization. with US manufacturing contract signed to mitigate supply-chain risk. -- Company ends second quarter with approximately $9.6 million in cash","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4588","BJDX","BK4082","BK4585","BK4099","BK4555","TM","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900393","title":"Bluejay Net Loss Widens to $2.32 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900393","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900393?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:12","pubTimestamp":1786565570,"startTime":"0","endTime":"0","summary":"Bluejay net loss widens to $2.32 million in Q2 FY26Bluejay Diagnostics posted a net loss of USD 2.32 million for the quarter ended June 30, 2026, widening from USD 1.96 million.Operating loss widened ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9lps6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549520","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549520?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:26","pubTimestamp":1785929213,"startTime":"0","endTime":"0","summary":"C3is  stock was up more than 65% in Wednesday's premarket activity after closing Tuesday with a 21% decreaseBluejay Diagnostics  shares were 38% higher pre-bell, extending an over 5% rise in the previous session.Julong  stock was up 37% after a 12% loss at the prior close.Gran Tierra Energy  shares were 48% higher after the company agreed to sell its oil business in Colombia and Ecuador to French oil and natural gas exploration and production company Maurel & Prom for an enterprise value of $1.33 billion.Jin Medical International  stock was up more than 28% following the release of its fiscal H1 results.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GTE","BK4570","DRLL","VDE","WTIU","XOP","BK4213","BK4082","DBE","BK4021","FTXN","DUG","BK7095","GUSH","PXE","IEO","IXC","USE","XES","DRIP","CISS","DBC","ZJYL","BK4129","BJDX","ERX","PXJ","BK4585","GTE.AU","BK4588","DIG","JLHL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653799188","title":"Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799188?lang=en_us&edition=fundamental","pubTime":"2026-07-23 05:48","pubTimestamp":1784756919,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762673","title":"Bluejay Diagnostics Initial Beneficial Ownership Statement Names Bank of America as 10% Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653762673?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:30","pubTimestamp":1784741418,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% ownerBluejay Diagnostics Form 3 disclosed Bank of America entities as 10% owners, reporting beneficial ownership","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1qTtnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU1791807156.HKD","LU1718418525.SGD","IYG","XLF","IE0034235188.USD","UYG","LU2129689605.HKD","LU0683600562.USD","LU2129689514.USD","LU1883839398.USD","LU2596442595.SGD","LU0149725797.USD","TFNS","LU2129689431.USD","LU0320765646.SGD","LU0070302665.USD","LU0128525689.USD","LU0234570918.USD","LU1880398554.USD","BK4585","LU0130518102.USD","LU0130102774.USD","LU2265009873.SGD","IE00BZ1G4Q59.USD","LU0203347892.USD","IYF","BK4534","LU0256863902.USD","LU1267930227.SGD","BK4588","BJDX","LU0980610538.SGD","LU1894683264.USD","LU1880398471.USD","LU0053666078.USD","FNCL","LU0203345920.USD","LU0314106906.USD","IE00BFXG1179.USD","BAC","LU0130103400.USD","IE00B1BXHZ80.USD","VFH","BK4082","LU1280957306.USD","LU1201861249.SGD","IE0001KFT4U8.USD","FTXO","KBWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927953","title":"Bluejay Diagnostics completes enrollment in SYMON-II study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927953?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:35","pubTimestamp":1784630118,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (BJDX) announced the successful completion of patient enrollment in its SYMON-II multicenter clinical validation study. The stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653055276","title":"Bluejay Diagnostics Announces Symon-ii Sepsis Study Enrollment Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2653055276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653055276?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:32","pubTimestamp":1784629961,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics announces SYMON-II sepsis study enrollment completionBluejay Diagnostics posted a press release on SYMON-II, confirming completion of enrollment in its multicenter clinical validat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL2rVsHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4082","BK4588","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","BJDX","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762202","title":"Bluejay Diagnostics - Preliminary Symon-ii Data Show 17% 28-day Mortality Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653762202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:30","pubTimestamp":1784629800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUABTRFJQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653276204","title":"Bluejay Diagnostics Announces Successful Completion of Enrollment in the Symon-ii Multicenter Clinical Validation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653276204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653276204?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:30","pubTimestamp":1784629800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUABTRFJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651149417","title":"HRT Financial LP Sells 34,938 Bluejay Diagnostics Shares for $48,913.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2651149417","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651149417?lang=en_us&edition=fundamental","pubTime":"2026-07-14 03:15","pubTimestamp":1783970101,"startTime":"0","endTime":"0","summary":"HRT Financial LP sells 34,938 Bluejay Diagnostics shares for $48,913.20HRT Financial LP reported a net sale of 29,109 Bluejay Diagnostics common shares across July 9-10.Position fell to 92,055 shares ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL9bKcCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HRT Financial LP Sells 34,938 Bluejay Diagnostics Shares for $48,913.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114913","title":"Bluejay Diagnostics Initial Beneficial Ownership Filing Shows HRT Financial LP Stake of 126,993 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114913?lang=en_us&edition=fundamental","pubTime":"2026-07-14 03:03","pubTimestamp":1783969393,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics initial beneficial ownership filing shows HRT Financial LP stake of 126,993 sharesBluejay Diagnostics Form 3 filed by HRT Financial LP, reporting 126,993 shares of common stock hel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL7dX7Br:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648501684","title":"Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2648501684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648501684?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:32","pubTimestamp":1783009921,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics, Inc. ($BJDX) announced an update on their ongoing clinical study. The Multicenter Symphony IL-6 Monitoring Sepsis ED Pilot Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-symphony-il-6-sepsis-pilot-keeping-investor-focus-on-er-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-symphony-il-6-sepsis-pilot-keeping-investor-focus-on-er-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644225397","title":"Bluejay Diagnostics files to sell 11.22M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2644225397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644225397?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:25","pubTimestamp":1781731509,"startTime":"0","endTime":"0","summary":"17:21 EDT Bluejay Diagnostics (BJDX) files to sell 11.22M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-11-22m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-11-22m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642413551","title":"Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2642413551","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642413551?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:47","pubTimestamp":1781045237,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has issued an update. At its June 9, 2026 annual meeting, Bluejay Diagnostics shareholders re-elected all incumbent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-shareholders-approve-stock-plan-and-flexibility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-shareholders-approve-stock-plan-and-flexibility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642490056","title":"Bluejay Diagnostics shareholders approve 600,000-share increase to 2021 stock plan reserve","url":"https://stock-news.laohu8.com/highlight/detail?id=2642490056","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642490056?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:27","pubTimestamp":1781040423,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics held its annual shareholder meeting on June 9, 2026.Shareholders backed an amendment allowing a reverse stock split within a 1-for-2 to 1-for-20 range; no split has been implemented.Investors adopted an amendment to the 2021 stock plan, lifting the share reserve by 600,000 to 600,061 shares.Shareholders ratified Wolf & Company as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL145Yz7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642843718","title":"Bluejay Diagnostics Completes Private Placement to Extend Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2642843718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642843718?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:52","pubTimestamp":1780959169,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On June 2, 2026, Bluejay Diagnostics entered into securities purchase and regi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-private-placement-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-private-placement-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.0751},{"period":"1month","weight":-0.3287},{"period":"3month","weight":-0.8266},{"period":"6month","weight":-0.5525},{"period":"1year","weight":-0.8524},{"period":"ytd","weight":-0.6881}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.09176},{"month":2,"riseRate":0.4,"avgChangeRate":-0.020494},{"month":3,"riseRate":0.4,"avgChangeRate":-0.104322},{"month":4,"riseRate":0.2,"avgChangeRate":-0.223757},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039698},{"month":6,"riseRate":0.4,"avgChangeRate":-0.217872},{"month":7,"riseRate":0.4,"avgChangeRate":-0.088216},{"month":8,"riseRate":0.2,"avgChangeRate":-0.172986},{"month":9,"riseRate":0.2,"avgChangeRate":-0.150059},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040237},{"month":11,"riseRate":0,"avgChangeRate":-0.194266},{"month":12,"riseRate":0.2,"avgChangeRate":-0.253394}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}